CN103458874A - 对组合物的改进和与组合物有关的改进 - Google Patents

对组合物的改进和与组合物有关的改进 Download PDF

Info

Publication number
CN103458874A
CN103458874A CN2012800165446A CN201280016544A CN103458874A CN 103458874 A CN103458874 A CN 103458874A CN 2012800165446 A CN2012800165446 A CN 2012800165446A CN 201280016544 A CN201280016544 A CN 201280016544A CN 103458874 A CN103458874 A CN 103458874A
Authority
CN
China
Prior art keywords
per liter
solution
aqueous solution
present
optional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012800165446A
Other languages
English (en)
Chinese (zh)
Inventor
C·森登
D·潘福德
F·莫瑞瑟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norgine BV
Original Assignee
Norgine BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101666.4A external-priority patent/GB201101666D0/en
Priority claimed from GBGB1101738.1A external-priority patent/GB201101738D0/en
Priority claimed from GBGB1200637.5A external-priority patent/GB201200637D0/en
Application filed by Norgine BV filed Critical Norgine BV
Priority to CN201710454883.7A priority Critical patent/CN107260661A/zh
Publication of CN103458874A publication Critical patent/CN103458874A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CN2012800165446A 2011-01-31 2012-01-31 对组合物的改进和与组合物有关的改进 Pending CN103458874A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710454883.7A CN107260661A (zh) 2011-01-31 2012-01-31 对组合物的改进和与组合物有关的改进

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1101666.4A GB201101666D0 (en) 2011-01-31 2011-01-31 Improvements in and relating to compositions
GB1101666.4 2011-01-31
GBGB1101738.1A GB201101738D0 (en) 2011-02-01 2011-02-01 Improvements in and relating to compositions
GB1101738.1 2011-02-01
GBGB1200637.5A GB201200637D0 (en) 2012-01-13 2012-01-13 Improvements in and relating to compositions
GB1200637.5 2012-01-13
PCT/GB2012/050195 WO2012104617A1 (en) 2011-01-31 2012-01-31 Improvements in and relating to compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201710454883.7A Division CN107260661A (zh) 2011-01-31 2012-01-31 对组合物的改进和与组合物有关的改进

Publications (1)

Publication Number Publication Date
CN103458874A true CN103458874A (zh) 2013-12-18

Family

ID=45563438

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710454883.7A Pending CN107260661A (zh) 2011-01-31 2012-01-31 对组合物的改进和与组合物有关的改进
CN2012800165446A Pending CN103458874A (zh) 2011-01-31 2012-01-31 对组合物的改进和与组合物有关的改进

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201710454883.7A Pending CN107260661A (zh) 2011-01-31 2012-01-31 对组合物的改进和与组合物有关的改进

Country Status (17)

Country Link
EP (2) EP2670391A1 (enExample)
JP (2) JP2014504628A (enExample)
KR (1) KR101852502B1 (enExample)
CN (2) CN107260661A (enExample)
AU (1) AU2012213180B2 (enExample)
BR (1) BR112013019418B1 (enExample)
CY (1) CY1125270T1 (enExample)
DE (1) DE202012013349U1 (enExample)
DK (1) DK2862566T3 (enExample)
EA (1) EA028925B1 (enExample)
ES (1) ES2914034T3 (enExample)
HR (1) HRP20220691T1 (enExample)
MX (1) MX360450B (enExample)
PL (1) PL2862566T3 (enExample)
PT (1) PT2862566T (enExample)
WO (1) WO2012104617A1 (enExample)
ZA (1) ZA201305342B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
NZ743984A (en) 2012-09-11 2019-10-25 Norgine Bv Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
JP6441890B2 (ja) 2013-03-15 2018-12-19 ブレインツリー・ラボラトリーズ，インコーポレイテッド 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
WO2016208781A1 (ko) * 2015-06-22 2016-12-29 주식회사 씨티씨바이오 장관 세척용 하제 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471954A (en) * 2009-07-17 2011-01-19 Norgine Bv Orange flavoured colon cleansing composition
CN102548580A (zh) * 2009-07-30 2012-07-04 诺金股份有限公司 包含聚乙二醇和电解质的溶液

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE477790T1 (de) * 2001-10-29 2010-09-15 Ajinomoto Kk Lösung zur darmreinigung
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471954A (en) * 2009-07-17 2011-01-19 Norgine Bv Orange flavoured colon cleansing composition
CN102548580A (zh) * 2009-07-30 2012-07-04 诺金股份有限公司 包含聚乙二醇和电解质的溶液

Also Published As

Publication number Publication date
MX2013008635A (es) 2013-11-04
PT2862566T (pt) 2022-06-02
DE202012013349U1 (de) 2016-06-27
ES2914034T3 (es) 2022-06-07
AU2012213180B2 (en) 2017-04-13
EP2862566A1 (en) 2015-04-22
EP2670391A1 (en) 2013-12-11
BR112013019418B1 (pt) 2022-03-29
KR20140007881A (ko) 2014-01-20
HRP20220691T1 (hr) 2022-07-08
PL2862566T3 (pl) 2022-06-20
EA028925B1 (ru) 2018-01-31
JP2018035181A (ja) 2018-03-08
JP2014504628A (ja) 2014-02-24
DK2862566T3 (da) 2022-05-16
CY1125270T1 (el) 2024-12-13
KR101852502B1 (ko) 2018-04-26
WO2012104617A1 (en) 2012-08-09
BR112013019418A2 (enExample) 2017-08-29
MX360450B (es) 2018-11-01
JP6498250B2 (ja) 2019-04-10
CN107260661A (zh) 2017-10-20
NZ613401A (en) 2016-03-31
EP2862566B1 (en) 2022-03-09
ZA201305342B (en) 2014-12-23
EA201300882A1 (ru) 2014-01-30

Similar Documents

Publication Publication Date Title
TWI478716B (zh) 包含聚乙二醇之濃縮溶液、包含其之容器與套組、製備其之方法及其用途
JP2002516860A (ja) 安定化剤としてアミノポリカルボン酸を含有する安定化抗ヒスタミンシロップ
JP6498250B2 (ja) 組成物の改良及び組成物関連
JP2007508313A (ja) メチルフェニデート溶液および関連する投与および製造方法
AU2012213180A1 (en) Improvements in and relating to compositions
WO2020212898A1 (en) Pharmaceutical oral liquid solution of ivacaftor
BR112020004453A2 (pt) composição para suplementação de cálcio
NZ613401B2 (en) Polyethylene Glycol Solutions for Use in the Treatment of Constipation
WO2005034910A1 (en) Oral liquid pharmaceutical compositions of sertraline
JPH01287027A (ja) ９−フルオロ−６，７−ジヒドロ−５−メチル−８−（４−メチル−１−ピペラジニル）−１，７−ジオキソ−１Ｈ，５Ｈ−ベンゾ［ｉｊ］キノリジン−２−カルボン酸塩酸塩一水和物の注射剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20131218